INCYTE CORP's ticker is and the CUSIP is 45337CAN2. A total of 22 filers reported holding INCYTE CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $180,000 | -12.6% | 122,000 | 0.0% | 0.00% | – |
Q4 2019 | $206,000 | +13.2% | 122,000 | 0.0% | 0.00% | – |
Q3 2019 | $182,000 | -10.3% | 122,000 | 0.0% | 0.00% | – |
Q2 2019 | $203,000 | -1.0% | 122,000 | 0.0% | 0.00% | – |
Q1 2019 | $205,000 | +28.1% | 122,000 | 0.0% | 0.00% | – |
Q4 2018 | $160,000 | -5.9% | 122,000 | 0.0% | 0.00% | – |
Q3 2018 | $170,000 | +1.8% | 122,000 | 0.0% | 0.00% | – |
Q2 2018 | $167,000 | -16.1% | 122,000 | 0.0% | 0.00% | – |
Q1 2018 | $199,000 | -11.9% | 122,000 | 0.0% | 0.00% | – |
Q4 2017 | $226,000 | -18.7% | 122,000 | 0.0% | 0.00% | – |
Q3 2017 | $278,000 | -8.3% | 122,000 | 0.0% | 0.00% | – |
Q2 2017 | $303,000 | -5.6% | 122,000 | 0.0% | 0.00% | – |
Q1 2017 | $321,000 | +31.6% | 122,000 | +1.7% | 0.00% | – |
Q4 2016 | $244,000 | +5.2% | 120,000 | 0.0% | 0.00% | – |
Q3 2016 | $232,000 | +95.0% | 120,000 | +71.4% | 0.00% | – |
Q2 2016 | $119,000 | +8.2% | 70,000 | 0.0% | 0.00% | – |
Q1 2016 | $110,000 | -95.8% | 70,000 | -95.9% | 0.00% | -100.0% |
Q4 2014 | $2,613,000 | – | 1,696,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 22,232,000 | $35,092,000 | 1.94% |
Nicholas Investment Partners, LP | 3,120,000 | $4,898,000 | 0.36% |
CSS LLC/IL | 3,500,000 | $5,577,000 | 0.34% |
Hudson Bay Capital Management LP | 2,500,000 | $3,954,000 | 0.19% |
ADVENT CAPITAL MANAGEMENT /DE/ | 3,937,000 | $6,226,000 | 0.10% |
PALISADE CAPITAL MANAGEMENT, LP | 1,402,000 | $2,216,000 | 0.07% |
Orbimed Advisors | 4,250,000 | $6,727,000 | 0.07% |
Citadel Advisors | 28,500,000 | $44,936,000 | 0.06% |
Calamos Advisors LLC | 4,960,000 | $7,851,000 | 0.05% |
GABELLI FUNDS LLC | 1,000,000 | $1,570,000 | 0.01% |